We are live on
!
Find out more
Group One Trading Portfolio holdings
AUM
$52.2B
1-Year Est. Return
104.56%
This Fund
S&P 500
This Quarter
Est. Return
+20.36%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,561.13%
AUM
$26B
AUM Growth
-$12B
(-32%)
Cap. Flow
-$15.4B
Cap. Flow
% of AUM
-59.14%
Top 10 Holdings %
Top 10 Hldgs %
26.02%
Holding
8,334
New
1,055
Increased
1,987
Reduced
3,543
Closed
1,412
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$58M |
| 2 |
Arm
ARM
|
+$57M |
| 3 |
Coinbase
COIN
|
+$30.9M |
| 4 |
Microsoft
MSFT
|
+$30.2M |
| 5 |
Amazon
AMZN
|
+$28.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$61.3M |
| 2 |
Advanced Micro Devices
AMD
|
+$58.9M |
| 3 |
Meta Platforms (Facebook)
META
|
+$54.6M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
+$35.1M |
| 5 |
Palantir
PLTR
|
+$33.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.22% |
| 2 | Financials | 1.78% |
| 3 | Consumer Discretionary | 1.72% |
| 4 | Healthcare | 1.04% |
| 5 | Communication Services | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
Arbutus Biopharma
ABUS
$857M
| $170K | ﹤0.01% |
65,967
+58,655
| +802% | +$152K |
|
3702
PUT
Cognex
CGNX
$10.9B
| $170K | ﹤0.01% |
4,000
-100
| -2% | -$3.89K |
|
|
CAN
3703
CALL
Canaan Creative
CAN
$127M
| $169K | ﹤0.01% |
111,400
-740,700
| -87% | -$1.26M |
|
3704
Pacira BioSciences
PCRX
$1.04B
| $169K | ﹤0.01% |
5,793
+3,508
| +154% | +$108K |
|
|
EVA
3705
CALL
DELISTED
Enviva Inc.
EVA
| $169K | ﹤0.01% |
384,400
+379,700
| +8,079% | +$199K |
|
|
ACRE
3706
PUT
Ares Commercial Real Estate
ACRE
$236M
| $169K | ﹤0.01% |
22,700
+11,200
| +97% | +$97.5K |
|
|
VRNA
3707
PUT
DELISTED
Verona Pharma
VRNA
| $169K | ﹤0.01% |
10,500
-33,200
| -76% | -$574K |
|
3708
Tradeweb Markets
TW
$21.4B
| $169K | ﹤0.01% |
+1,619
| New | +$163K |
|
3709
CALL
Banco Macro
BMA
$5.88B
| $169K | ﹤0.01% |
3,500
-16,100
| -82% | -$569K |
|
3710
PUT
Mirum Pharmaceuticals
MIRM
$6.46B
| $168K | ﹤0.01% |
6,700
-200
| -3% | -$5.5K |
|
3711
CALL
Interface
TILE
$1.99B
| $168K | ﹤0.01% |
10,000
-100
| -1% | -$1.38K |
|
3712
CALL
Lantheus
LNTH
$6.49B
| $168K | ﹤0.01% |
2,700
-173,100
| -98% | -$10.2M |
|
3713
CALL
BlackLine
BL
$1.84B
| $168K | ﹤0.01% |
2,600
+1,600
| +160% | +$97.1K |
|
3714
PUT
DigitalBridge
DBRG
$2.93B
| $168K | ﹤0.01% |
8,700
+1,500
| +21% | +$28.2K |
|
3715
CALL
Ambev
ABEV
$48.1B
| $167K | ﹤0.01% |
67,500
-53,700
| -44% | -$140K |
|
3716
CALL
Gencor Industries
GENC
$209M
| $167K | ﹤0.01% |
+10,000
| New | +$161K |
|
3717
CALL
RCM Technologies
RCMT
$201M
| $167K | ﹤0.01% |
7,800
| – | – |
|
3718
PUT
Pulse Biosciences
PLSE
$2.43B
| $166K | ﹤0.01% |
19,100
-2,100
| -10% | -$19.3K |
|
3719
Masco
MAS
$14.1B
| $166K | ﹤0.01% |
+2,107
| New | +$152K |
|
3720
CALL
The Honest Company
HNST
$402M
| $166K | ﹤0.01% |
41,000
-31,400
| -43% | -$106K |
|
3721
Aclaris Therapeutics
ACRS
$726M
| $166K | ﹤0.01% |
133,831
+56,630
| +73% | +$67.5K |
|
|
GTLS
3722
PUT
DELISTED
Chart Industries
GTLS
| $165K | ﹤0.01% |
1,000
-4,700
| -82% | -$631K |
|
|
FPI
3723
CALL
Farmland Partners
FPI
$408M
| $164K | ﹤0.01% |
14,800
+1,400
| +10% | +$15.7K |
|
3724
Synopsys
SNPS
$74.4B
| $164K | ﹤0.01% |
+287
| New | +$158K |
|
3725
ProFrac Holding
ACDC
$731M
| $164K | ﹤0.01% |
+19,600
| New | +$151K |
|
Similar funds
SCP
Group One Trading's Q1 2024 Portfolio in Review
As of Q1 2024, Group One Trading held 8,334 positions worth $26B, down 32% from $38B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Group One Trading withdrew a net $15.4B in Q1 2024, closing 1,412 positions and reducing 3,543 holdings. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $24.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.2% of assets, up from 2.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Group One Trading opened a new position in Arm worth $67.3M.
- Group One Trading's largest Q1 2024 buy was Arm: 538,130 shares worth $67.3M.
- Group One Trading added most to Alibaba in Q1 2024, an estimated $58M increase.
- Group One Trading's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $61.3M.
- Group One Trading fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $24.3M.
- Group One Trading's ten largest holdings make up 26% of its $26B portfolio in Q1 2024.
- Group One Trading opened 1,055 new positions and closed 1,412 in Q1 2024.
- Group One Trading's portfolio value fell 32% quarter-over-quarter to $26B.
Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.